Characterization and serotype distribution of Aggregatibacter actinomycetemcomitans detected in a population of periodontitis patients in Spain. by Blasi, Andrea
Università degli Studi di Napoli “Federico II” 
Scuola di dottorato in medicina clinica e sperimentale 
Dipartimento di Scienze Odontostomatologiche e Maxillo-Facciali 
 
 
 
 
Dottorato di ricerca in  
Scienze Odontostomatologiche 
Coordinatore: prof. Sandro Rengo 
 
XXII CICLO 
 
TESI DI DOTTORATO 
 
Characterization and serotype distribution of 
Aggregatibacter actinomycetemcomitans detected 
in a population of periodontitis patients in Spain. 
 
 
 
Tutor        Candidato 
Ch.mo prof. 
 Sergio Matarasso      dott. Andrea Blasi 
 
 
Anni Accademici 2006-2009 
1 
 
Characterization and serotype distribution of 
Aggregatibacter actinomycetemcomitans 
detected in a population of periodontitis 
patients in Spain. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 
 
INDEX 
Characterization and serotype distribution of Aggregatibacter actinomycetemcomitans 
detected in a population of periodontitis patients in Spain. ............................................... 1 
SUMMARY ........................................................................................................................ 4 
Objective: ..................................................................................................................... 4 
Materials and methods: ............................................................................................... 4 
Results: ......................................................................................................................... 4 
Conclusions: ................................................................................................................. 4 
INTRODUCTION ................................................................................................................ 6 
Aggregatibacter actinomyicetemcomitans as a periodontal risk factor ..................... 6 
Serotype characterization of Aggregatibacter actinomyicetemcomitans .................. 6 
Aggregatibacter actinomyicetemcomitans’s toxins: leukotoxic and cytolethal 
distending toxin ........................................................................................................... 7 
Rationale for research .................................................................................................. 9 
MATERIALS AND METHODS ........................................................................................... 11 
Patients’ selection and samples’ reception ............................................................... 11 
Recording of clinical data ........................................................................................... 12 
Culture, isolation and storage .................................................................................... 12 
Culture techniques ..................................................................................................... 13 
Isolation of genomic DNA .......................................................................................... 13 
Serotyping of strains .................................................................................................. 15 
Detection of putative leukotoxin overproducers ...................................................... 16 
Detection of Cdt’s polymorphism  in A. a. ................................................................. 17 
STATISTICAL ANALYSIS ................................................................................................... 18 
RESULTS.......................................................................................................................... 19 
Serotype distribution ................................................................................................. 19 
LtxC promoter deletion .............................................................................................. 19 
Cdt operon detection ................................................................................................. 20 
Subgroup analyses ..................................................................................................... 20 
DISCUSSION .................................................................................................................... 23 
Serotypes’ distribution ............................................................................................... 23 
Distribution of ltx gene .............................................................................................. 24 
Distribution of cdt gene ............................................................................................. 25 
Evaluation of subgroup analysis ................................................................................ 25 
CONCLUSIONS ................................................................................................................ 27 
3 
 
FUTURE RESEARCH PROPOSALS .................................................................................... 28 
FIGURES AND TABLES ..................................................................................................... 29 
Table 1 Primers selected for the PCR serotyping of A. a. .......................................... 29 
Table 2 Primers used for the detection of the presence of the cdt operon .............. 30 
Table 3 Distribution of serotype strains for A. a. ....................................................... 30 
Table 4 Distribution of ltx gene .................................................................................. 31 
Table 5 Distribution of cdt gene ................................................................................ 31 
Table 6 Forms of periodontitis ................................................................................... 32 
Table 7 Presence of cdt gene ..................................................................................... 33 
Table 8 Serotypes ....................................................................................................... 34 
Figure 1 and 2 Aggregatibacter actinomycetemcomitans on DENTAID-1 plates ...... 35 
Figures 3 and 4 Examples of different results for PCR performed with serotypes’ 
primers. Electrophoresis on 2.0 % agarose gel with  λ-Hind-III and 1kb dimensional 
markers, respectively. ................................................................................................ 35 
Figure 5 Examples of results for PCR performed with ltx primers. Electrophoresis on 
1.0 % agarose gel with 1kb dimensional marker. ...................................................... 36 
Figure 6 Examples of results for PCR performed with cdt primers. Electrophoresis 
on 1.0 % agarose gel with 1kb dimensional marker. ................................................. 36 
REFERENCES ................................................................................................................... 37 
 
 
 
 
 
 
 
 
 
4 
 
SUMMARY 
Objective: 
To investigate the serotype distribution of Aggregatibacter actinomycetemcomitans (A. 
a.) and the polymorphism of the genes that codify the leukotoxin (ltx) and the operon of 
the cytolethal distending toxin (cdt) in periodontitis patients in Spain. 
Materials and methods: 
Forty A. a.-positive periodontitis patients were included in the study (mean age 45±7.8 
years, 62.5 % female) and their clinical periodontal status was assessed. On average, 1 to 
2 isolates from each patient were subcultured and characterized by specific PCR 
reactions. 
Results: 
Serotype distribution analysis concludes that the most frequent serotype was a and that 
29 patients showed monoinfection. The 11 patients that showed coinfection were 
infected mostly with serotypes a and b. 
From these 40 isolates 15 corresponded to serotype a, 8 to serotype b and 6 to serotype 
c. Monoinfection with serotypes d, e or f was not found.  
Further characterization of these samples with leukotoxin specific PCR reaction showed 
that none of the 40 samples presented the 530-bp deletion called Δ530 in the 
leukotoxin’s promoter region, which characterizes the JP2 strain.  
As for the Cdt, the operon that codifies for the toxin was present in 85 % of the samples. 
Conclusions:  
The most common serotypes were a and b. Serotype a was the most frequent in 
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monoinfections, while serotypes d, e and f were not detected. In the majority of 
samples, operon that codifies the cdt (85%) and the genes responsible for the 
codification of leukotoxin (100%) were found. None of the isolates belonged to the JP2 
strain. 
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INTRODUCTION  
Aggregatibacter actinomyicetemcomitans as a periodontal risk factor 
Periodontal diseases are caused by microorganisms colonizing the subgingival biofilm
1
. 
One of these pathogenic microorganisms, Aggregatibacter actinomycetemcomitans (A. 
a.), has received particular attention and is regarded as a major pathogen in periodontal 
diseases
2,3,4,5
 and as a key factor in the etiology of early onset and refractory forms of 
periodontal disease. This notion is based primarily on association studies, conducted in 
North America and Europe, linking the organisms to the disease and showing a 
correlation between worse than expected treatment outcomes and high levels of A. a. 
after therapy, but its presence has also been identified as a risk factor for the onset of 
periodontitis in a study performed recently by Van der Velden and coworkers
6
. On the 
other hand, it has been reported that A. a. can be detected with considerable frequency 
also in subjects without clinical evidence of periodontal disease. If a putative pathogen 
can be detected frequently in healthy subjects, this may suggest that not all humans are 
equally susceptible or that there is variation in virulence and pathogenic potential of the 
pathogen.  
Serotype characterization of Aggregatibacter actinomyicetemcomitans 
An intra-species division of this microorganism is the one termed as serotypes. The 
species is represented by 6 serotypes (from a to f)
7
 that were, at first, identified with 
monoclonal antibodies. Nowadays a more simple and fast technique to analyze the 
serotypes of A. a. is represented by the polymerase chain reaction (PCR), performed 
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with specifically designed primers. Serotype-dependent variance in virulence has been 
suggested for A. a. and Porphyromonas gingivalis, since both microbial species have 
several serotypes that differ in virulence
8,9
. A. a.’s serotype b has been more frequently 
associated to periodontitis lesions, while serotypes a and c have shown a stronger 
association with periodontal health
9,10,11,12
. Yang  found out that serotype b was more 
often found in aggressive than chronic forms of periodontitis in a big population in 
Philadelphia, PA - USA
13
. The global serotype distribution is not homogeneous
14,15
 and 
the association between serotype and periodontal status may be depending on the 
geographical location and/or ethnical status of the study population
16,17
. Most studies 
defend the concept of monoinfection putting forward that one subject tends to be 
colonized by one unique serotype
10
 while several studies found that, on the contrary, 
subjects with two or three serotypes can also be detected
18,19,20,21
. 
Aggregatibacter actinomyicetemcomitans’s toxins: leukotoxic and cytolethal 
distending toxin 
A. a. shows a high degree of genetic diversity
22,23
 but almost all the identified clones 
have demonstrated in vitro and in vivo capability of inducing periodontitis, and that is 
particularly obvious when assessing its main virulence factor: this bacteria produces a 
leukotoxin that specifically destroys human polymorphonuclear leukocytes and 
macrophages
24
. The toxic activity of this factor, which belongs to the group of the so 
called Repeats in Toxin (RTX), depends on its capability of forming pores in the 
membrane of macrophages and leukocytes
25
, but it doesn’t affect epithelial or 
endothelial cells, nor fibroblasts. 
8 
 
Previous studies have revealed variations in leukotoxin’s production among different 
isolates
24,8
. The molecular mechanism of high-level production was identified as a 530-
bp deletion in the region upstream of the leukotoxin gene operon (lxt) encoding the 
toxin, thereby bringing a second strong promoter into context. The vast majority of 
strains of this highly leukotoxic clone were isolated from subjects of African descent. 
Recently, a study by Haubeck and coworkers
26
 demonstrated, in a population based 
longitudinal study of 700 adolescents, that the JP2 strain of A.  a. can be considered as 
an aetiological agent of the aggressive form of periodontitis in adolescents living in or 
originating from north and west Africa. Individuals who carried the JP2 clone of A. a. had 
a significantly increased risk of periodontal attachment loss, either alone (relative risk 
18.0) or together with non-JP2 clones of A. a. (RR 12.4). A much less pronounced disease 
risk was found in those carrying non-JP2 clones only (RR 3.0). 
Another virulence factor of this bacterial species is the cytolethal distending toxin (Cdt) 
which is a recently characterized genotoxin that blocks cell cycle progression in specific 
classes of eukaryotic cells and cell lines. This holotoxin is made up of three subunit 
proteins designated Cdt A, CdtB and CdtC. The Cdt has, to date, only been found in A. a. 
among bacterial species indigenous to the human oral cavity
27
. Several types of oral 
epithelial cells and T lymphocytes are particularly susceptible to the A. a.’s Cdt. 
Therefore, expression of this relatively unique secreted bacterial virulence factor may, in 
part, play a role in the pathogenic capacity of this microorganism. Literature reveals 
once more, that not every A. a. presents cytotoxic Cdt activity. Based on a study by 
Ahmed
28
 the 86% of A.  a. isolates presented the complete operon and its characteristic 
cytotoxic activity. A work by Tan and coworkers showed a close association between 
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aggressive forms of periodontitis and A.  a. strains that belonged the Cdt genotype
29
. 
In summary, numerous studies show the wide range of genetic diversity of A.  a. strains 
isolated throughout the world
10,22,12,23,30,31,32,33,34
 
 
These genetic variation among natural isolates suggest a variability in the virulence 
potential of strains. Actually Kaplan, evaluating six characteristics of A. a. (serotype, 16S 
rRNA, ltx, flp-1, cdt, and AP-PCR genotypes) identified three phylogenetic clusters. One 
cluster consisted of serotype b strains, a second cluster consisted of serotype c strains, 
and a third cluster consisted of serotype a, d, e, and f strains. Serotype b and c strains 
formed distinct, monophyletic groups within the serotype {b,c} cluster while serotypes 
a, d, e and f formed an independent group. On the bases of these findings Kaplan 
suggested the hypothesis that LJP may have two different etiologies and epidemiologies: 
in Caucasians LJP may be associated with diverse A. a. clones acting as opportunistic 
pathogens, whereas in some Africans and African-Americans LJP may be associated with 
JP2-like strains acting as exogenous pathogens. It is also possible that JP2-like strains are 
acting as opportunistic pathogens that are simply more prevalent in Africans and 
African-Americans, who have an increased susceptibility to LJP for other reasons, 
perhaps related to host determinants
7
. 
Rationale for research 
In Spain, to the best of our knowledge, no single study has been conducted with the aim 
to characterize the A. a. isolates in Spanish periodontitis patients. For this reason, our 
aim was to investigate the serotype distribution of A.  a. and the polymorphism of the 
genes that codify the leukotoxin and the operon of the cytolethal distending toxin in 
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periodontitis patients in Spain.  
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MATERIALS AND METHODS  
Patients’ selection and samples’ reception  
The plaque samples used in this study were obtained from a consecutive series of 
subgingival microbial samples forwarded to the Laboratory of Microbiology, Faculty of 
Dentistry, University Complutense, Madrid, Spain, over 18 months from January 2007 to 
July 2008.  
Microbiological samples were collected by periodontists in private practices as well as 
postgraduate students in the Postgraduate Clinic of Periodontology in the same Faculty 
of Dentistry. Each sample was accompanied by clinical information including patient age, 
gender, clinical diagnosis, brief clinical history, smoking status, sample sites and time 
and date of sampling. Pocket depth, recession and presence or absence of plaque, 
bleeding on probing and suppuration were also recorded on the 4 selected sites per 
patient, from which samples were taken. 
Samples were taken from the deepest pocket in each quadrant
35
. At selected sites, 
supragingival plaque was carefully removed to avoid bleeding using sterile gauze and / 
or curettes. Then, these sites were dried with sterile cotton rolls and gentle air blowing. 
Two consecutive sterile medium size paper points (Maillefer, Ballaigues, Switzerland) 
were inserted as deep as possible in the pocket, and left in place for 10 seconds. The 
paper points were transferred to a vial containing 1.5 ml of Reduced Transport Fluid 
(RTF)
36
, and pooled with all the other paper points. The vial, kept at room temperature, 
was sent to the laboratory and processed within 24 hours. 
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Recording of clinical data 
Only  patients presenting 4 locations with probing depth deeper than 4 mm and at least 
4 locations with clinical attachment loss higher than 4 mm were included in the study. 
Subjects with less than 16 teeth and patients who had taken any antibiotic medication 
during the previous 3 months were excluded. 
A periodontal diagnosis was established for each patient according to the clinical 
diagnostic classifications approved by the American Academy of Periodontology in 
1999
37
. Patients with untreated periodontitis were divided into chronic and aggressive 
form. In addition, patients already treated but showing signs of disease or a less than 
optimal treatment outcome, were placed in an additional category named as 
“refractory”. 
Culture, isolation and storage 
 
Samples were homogenized with a vortex and 10-fold serially diluted in phosphate 
sodium buffer (PBS) and aliquots of 100 µl were plated in two different media: Blood 
agar medium (No. 2 of Oxoid; Oxoid Ltd., Basingstoke, England), with 5% horse blood, 
and haemin (5 mg/l) and menadione (1 mg/l) and Dentaid-1 medium
38
. 
The blood agar plates were studied after 7 and 14 days of anaerobic incubation (80% N
2;
 
10% H
2
; 10% CO
2
 at 37°C). Plates were carefully examined for the identification of 
Porphiromonas gingivalis, Prevotella intermedia/nigrescens, Tannerella forsythia, 
Parvimonas micra, Capnocytophaga spp., Eikenella corrodens and Fusobacterium spp., 
based on the morphology of the colony. Colonies of each bacterial species were 
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counted, as the total number of colonies in a representative plate (between 30 to 300 
colonies). The Dentaid-1 plates, used for selective isolation and growth of A. a., were 
incubated for 3-5 days at 37°C in air with 5% CO
2
. After this period, plaques were 
carefully examined to determine the presence of A. a.. The identification of A. a. was 
based on three typical features: the colonies’ morphology, a positive response to 
catalase test and the results of a set of specific enzymes (RapID NH system, Innovative 
Diagnostics Systems, Inc., Decatur, GA - USA). Some example of cultured A.a. on 
DENTAID-1 plates is shown at Figures 1 and 2. A maximum of 2 isolates per subject were 
subcultured and purified. All original samples were stored in cryogenic vials containing 
polypropylene beads (CryoBeads
TM
, Hardy Diagnostics, Santa Maria, CA - USA) at -80°C 
until further use.  
Culture techniques 
Cells proceeding from stored samples were sowed in DENTAID-1 agar plates and 
incubated at 37°C in air with 5% CO
2
. After 3 days a single colony from every plate was 
passed into a new, sterile DENTAID-1 agar plate. This step was repeated for at least two 
times, then a single colony per plate was passed a into a sterile plastic tube filled with 10 
ml of brain heart infusion (BHI) broth (BBL™ Brain Heart Infusion, Oxoid, Basingstoke, 
England). 
Isolation of genomic DNA 
Cells were harvested by centrifugation and re-suspension in 1 ml of tris-HCl 10 mM, 
EDTA 0.8 mM (pH 8.0) and lysozyme (final concentration 5.0 mg/ml). After incubation at 
37°C for 30 min, proteinase K, RNAase and sodium dodecyl sulfate (SDS), were added to 
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a final concentration of 2 mg/µl, 1 mg/µl and 1 %, respectively. The mixture was 
incubated at 37°C for 30 minutes. The DNA was then extracted with equal volumes of 
phenol (saturated with 10 mM Tris-HCl, pH 8.0) and phenol-chloroform-isoamyl alcohol 
(25:24:1). Bulk nucleic acids were precipitated from the solution using ethanol followed 
by centrifugation (12.000 rpm) for 10 min. The DNA precipitate was resuspended in 50 
µl of sterile distilled water. 
The phenol-chloroform technique was chosen after comparing three different methods 
for extracting DNA: extraction of DNA by using the Boiling Lysis procedure, phenol-
chloroform method and G-NOME
®
 DNA isolation kit (MP Biomedicals LLC, CA, USA). For 
this purpose, three random plates of cultivated reference strains of A. a. (ATCC 29523 
and ATCC 29524) were chosen. Then, the three DNA extraction techniques were 
performed for each plate. The G-NOME
®
 DNA isolation kit was used according to the 
manufacturer’s instruction. For the Boiling Lysis procedure every sample was passed to a 
new sterile Eppendorf vial with 200 µl of sterile distilled water and dispersed by 
vortexing at high-speed for 3 minutes. After vortexing, the paper points were removed 
and were incubated at 103°C for 10 minutes in a thermal block, to obtain cell wall lysis. 
Then, the samples were frozen at -20°C for 10 minutes. The samples were centrifuged at 
12000 rpm for 10 minutes, and the supernatant recuperated. The raw DNA extracted 
with this method was immediately purified by using the GFX Purification kit (GE 
Healthcare, UK), and was eluted in 50µl of sterile distilled water and stored at -20°C 
pending PCR analysis 
The phenol-chloroform method proved to be the most efficient technique in terms of 
costs-benefits, as it provided a sufficient amount of high quality DNA. However this 
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technique is highly operator-dependent and it required a larger apprenticing period to 
obtain standardized results.  
The result of the DNA extraction was assessed by electrophoresis. A 5 µl aliquot of 
extracted DNA was electrophoresed through a 1.0 % agarose gel, in Tris- Acetate EDTA 
(TAE) buffer. The gel was stained with ethidium bromide (10 µg/ml) and visualized on an 
UV transilluminator. 
Serotyping of strains 
Serotypes a to f were determined by PCR technique, based on specific sequences from 
the gene clusters responsible for the O-polysaccharide that characterizes the distinct 
serotypes. The PCR reaction was performed with the specific primers described by 
Kaplan
7
. For serotypes a to f a PCR was performed. The sequences of the primers used 
are listed in Table 1. 
The PCR reaction was performed in a 25 μl final volume containing 2.5 μl of 10x PCR 
buffer, 1.0 μl of 25mM MgCl
2
, 0.5 μl of 10 mM deoxynucleoside triphosphates, 0.5 U Taq 
DNA polymerase (Invitrogen Corporation, CA, USA), 1.0 μl of 25 μM primers and 2 µl of 
genomic DNA. The PCR assays are performed with a Veriti® 96-Well Thermal Cycler 
(Applied Biosystems Inc., Foster City, CA - USA). After the initial step of denaturation at 
96 °C for 3 min, a total of 35 PCR cycles were performed; each cycle consisted of 30 
seconds of denaturation at 95°C, 1 minute of annealing at 55°C and 72°C for 2 minutes, 
and a final step of extension at 72°C for 10 minutes. 
Positive and negative controls were included for each performed PCR: as positive 
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controls reference strains ATCC 29523 and ATCC 29524 were used, while sterilized 
distilled water was used as negative control. 
A 15 μl aliquot of each PCR was added to 2 ml of gel loading dye (0.25% bromophenol 
blue, 50% glycerol, 100mM EDTA pH 8.0) and electrophoresed through a 2.0 % agarose 
gel in 1X TAE buffer. The PCR products are visualized by staining with ethidium bromide 
(10 mg/ml) and visualized under UV illumination. 
Detection of putative leukotoxin overproducers 
The deletion of 530 bp in the promoter region of the leukotoxin gene was determined in 
every isolate by means of PCR.  
The PCR primers and conditions for detecting the JP2 strain were those described by 
Haubek et al.
14
. The PCR reaction was performed in a 25 μl final volume containing 2.5 μl 
of 10x PCR buffer, 1.0 μl of 25mM MgCl
2
, 0.5 μl of 10 mM deoxynucleoside 
triphosphates, 0.5 U Taq DNA polymerase (Invitrogen Corporation, CA, USA), 1.0 μl of 25 
μM primers and 2 µl of genomic DNA. 
 PCR primer upstream from the deletion had the sequence 5´-
CAGATCAAAACCTGATAACAGTATT-3´, and the primer downstream from the deletion had 
the sequence 5´-TTTCTCCATATTCCCTCCTTCTGT-3´. 
The PCR temperature profile included an initial step of denaturation at 94 °C, a total of 
30 cycles of denaturation for 1 min at 94°C, annealing for 1 min at 60°C, and a final step 
of extension at 72°C for 2 min. The PCR fragment of 504 bp indicated deletion of 530 bp 
corresponding to the JP2 strain whereas a PCR fragment of 1034 bp indicated no 
17 
 
deletion in the A. a.’s leukotoxin operon. Positive and negative controls were included in 
the PCR: as positive controls reference strains ATCC 29523 and ATCC 29524 were used, 
while sterilized distilled water was used as negative control. The molecular weights of 
the PCR products were determined by visualization and comparison with standard 
molecular weights markers using agarose gel electrophoresis. 
Detection of Cdt’s polymorphism  in A. a.  
The presence of the operon that codifies for the Cdt toxin was also determined by 
means of PCR using the same procedure previously described for Ltx but using the 
primers that amplify the complete operon CdtA1 and CdtC2, which are listed in Table 2. 
The total molecular weight of the amplified segment was of 2016 bp when the complete 
operon was present. The PCR products were also determined by visualization in 1.0 % 
agarose gel. 
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STATISTICAL ANALYSIS 
Descriptive statistics, including frequency distribution, were used to characterized the 
sample in term of the different serotypes, the polymorphism of the genes that codify 
the leukotoxin and the operon of the cytolethal distending toxin. 
Different subgroup analyses were performed to compare patients with different clinical 
diagnosis chronic, aggressive or refractory, serotype, the presence of leukotoxin 
overproducers and the cdt gene. 
These groups were related to other variables including age, gender, periodontal 
attachment level, probing pocket depth, bleeding on probing (0/1), plaque index (0/1) 
(at sampled sites), suppuration (0/1) and smoking habits.  
For parametric variables ANOVA test with Bonferroni adjustment was used to determine 
the presence of statistically significant differences between groups, while the Pearson’s 
chi-square test was used in case of non-parametric variables. In case of dichotomous 
variables and small samples the Fisher’s exact test was preferred. 
All statistical analysis were performed using SPSS v. 13.0 software (SPSS Inc., Chicago, IL 
– USA) 
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RESULTS 
In total, 720 samples were received in that period, and 696 fulfilled the predetermined 
inclusion criteria. Among them, 42 (6 %) were positive for A. a. All the samples evaluated 
proceeded from Caucasian individuals. Two of the A. a. strains were contaminated and 
lost during the purification phase and only 1 to 2 isolates from 40 patient samples were 
kept at -80°C and one strain per patient was further analyzed. 
Serotype distribution 
From the 40 isolates, the predominant serotype was type a (37.5%), whereas serotypes 
b and c showed a distribution of 20 % and 15 % respectively. Serotypes d, e and f were 
not detected. More than one serotype was found in 27.5% of the patients, most of them 
were coinfections of serotypes a and b (54%). None of the isolated strains were non- 
typeable. Results are showed in table 3. Some of the products of PCR with serotypes’ 
primers are shown in figures 3 and 4. 
LtxC promoter deletion 
The results for the presence of a 530-bp deletion in the promoter region of the LtxC 
gene of A. a. show that none of the Spanish isolates belonged to the highly leukotoxic 
strain JP2. A clear band equivalent to a molecular weight of 1034-bp is appreciable in 
the 1.0 % agarose gel for every strain. Results are showed in table 4. Figure 5 shows a 
picture of an electrophoresed gel with products of PCR with ltx primers 
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Cdt operon detection 
The PCR products determined by visualization in 1% agarose gel showed that 34 of the 
40 isolates presented an amplified segment of 2016 bp.  
85 % of the isolates presented the complete operon of the Cdt gene while in 15 % the 
operon that codifies for the Cdt toxin was not present. Results are shown in table 5.  
Figure 6 shows an electrophoresed gel with products of PCR with cdt primers 
Subgroup analyses 
Data used for the subgroup analysis based on periodontitis groups, cdt and serotypes 
are reported in tables 6, 7 and 8 respectively. 
a)  periodontitis 
32.5% patients were diagnosed with aggressive periodontitis, which is characterized by 
rapid attachment loss, bone loss and familial aggregation
39
. 47.5% were diagnosed with 
chronic periodontitis characterized by having at least 4 sites with pockets depth > 4mm, 
and at least four sites with attachment level measurements < 4mm. 
As we can observe from the subgroup analysis, refractory patients showed less probing 
pocket depths, more suppuration, and more coinfections (4 out of 8 patients). 
Aggressive periodontitis patients were younger and harbored half of the 8 serotype b 
strains. Chronic periodontitis patients demonstrated the lower percentage of bleeding 
on probing. 
The ANOVA test with Bonferroni adjustment revealed a statistically significant difference 
for patients’ age between the aggressive periodontitis groups and the chronic 
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periodontitis group. 
Gingival recession was statistically significant higher in the refractory group when 
compared with the aggressive group, while there was no significant difference between 
chronic and aggressive groups, or refractory and chronic groups. 
The frequency of non smokers versus smokers (including former smokers) was 
homogenous between patients with chronic periodontitis and refractory periodontitis 
while it was significantly increased in patients presenting aggressive periodontitis. 
b) Cdt operon 
A positive result for cdt was largely present in the analyzed samples, and this result 
doesn’t seem to depend on serotypes’ distribution. Nevertheless while every serotype c 
patient presented a positive cdt result, only 62,5% of the patients with coinfection 
presented cdt genes. No differences are present regarding clinical variables between cdt 
positive and cdt negative patients. 
c) serotypes 
While there is a significantly higher percentage of females with serotype a, a higher 
percentage of men shows coinfections, although this data is not statistically significant.  
No other significant differences could be evicted from these data, but there seems to be 
a tendency toward a higher plaque index and suppuration scores for those patients with 
serotype c or coinfections.  
The proportion of serotype b in subjects with cultivable A. a. and aggressive 
periodontitis was 10 % higher than that in subjects with cultivable A. a. and chronic 
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periodontitis. 
A study by Yang reported that serotype b accounted for the majority of serotypes in 
patients with aggressive periodontitis whereas there was no difference in the 
distribution of serotypes a, b and c in patients with chronic periodontitis in a sample of 
115 subjects in the University of Pennsylvania
13
. 
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DISCUSSION 
The cumulative frequency detection of A.  a. in Spanish adult periodontal patients by 
culture techniques was estimated around the 6 %.  
In a previous study performed in Spain a prevalence of 6.3 % was also detected in 
periodontitis patients with culturing techniques and the same specific medium Dentaid-
1, while a prevalence of 18.8% was reported when using PCR methods
40
. A similar value 
(3.2%) was also reported in another study of our group with a comparable population in 
Spain
41
 but, in this case, a different culture medium was used (Tryptic Soy Serum 
Bacitracin Vancomycin Agar or TSBV) which demonstrated a lower recovery rate
37
.  
 Epidemiologic studies in adults showed that the prevalence of these microorganism 
varies substantially. The prevalence of A.  a. was estimated around 3% to 38% in the 
United States
42,43,44,45
, 15% in Sri Lanka
46
, 83% in China
47
, 93% in Thailand
48
, 47.7% in 
Germany and 26.7% in Korean periodontal patients
49
. 
Serotypes’ distribution 
This study examined the distributions of the different serotypes in culture positive 
plaque samples from Spain. We observed that from these 40 isolates, 15 corresponded 
to serotype a, 8 to serotype b and 6 to serotype c. Monoinfection with serotypes d, e or 
f was not found, this is in accordance with previous studies which have demonstrated 
that the prevalence of A. a. serotypes in populations from geographically distant regions 
show three predominant serotypes (a, b, c). 
In the United States, serotype b strains were more frequently isolated from patients 
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with localized juvenile periodontitis (LJP) than other disease-types or periodontally 
healthy subjects
10,12
. According to Listgarten, elevated responses to serotype a were 
more common in chronic periodontitis
50
. Our study confirms those data, since we found 
a higher percentage of serotype a strains in chronic periodontitis patients. 
On the contrary, Dogan reported that serotype a was a major serotype in LJP but the 
results for adult periodontitis showed no differences between the distributions of 
serotypes a, b and c
51
. 
A higher frequency of serotype b was reported in Finnish patients with periodontitis, 
while serotype c was more related to periodontally healthy subjects
19,12
. 
Predominance of serotypes other than b, however, has been reported from other parts 
of the world. In Korea
18
 and Japan
52
, for example, serotype c was frequently observed in 
plaque samples from sites with pathology. Yamamoto reported that serotypes d, e and 
untypeable strains were found in Japanese subjects at the following rates, 5%, 23% and 
10% respectively
53
. These serotypes have been recognized more recently
50,21
 and they 
are less frequently found than a, b and c
8,20,54
. 
Distribution of ltx gene 
The highly leukotoxic strain of A. a. has not been found in any of our patients. This result 
confirms the literature’s reports. Previous studies have demonstrated, in fact, that JP2 
clone of A. a. infects more frequently people of African descent
30,55
 than northern 
Europeans
23
, Chinese
56,21
 or people of Asian descents in the United States
31
. 
 In a cross sectional study in Brazil, greater clinical attachment loss was associated with 
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infection by highly leukotoxic A. a.. This result is consistent with the recent longitudinal 
study performed by Haubek in Morocco were individuals who carried the JP2 clone of A. 
a. had a significantly increased risk of periodontal attachment loss
25
.  
Distribution of cdt gene 
In 34 out of the 40 strains of periodontitis patients (85 %) cdt gene polymorphism has 
been detected. The prevalence in A. a. of this toxin is extremely variable, Ahmed et al. 
found 43 of 50 strains from periodontitis patients contained all three cdt genes and 
expressed Cdt activity
27
. In another study, PCR revealed that only 13 out of 106 diseased 
sites were positive for this genes
57
, Fabris also reported that 39 out of 40 were present 
in another patient cohort
58
. 
Evaluation of subgroup analysis 
Data proceeding from our population confirm the previous studies. In periodontal 
patients infected with A. a., aggressive periodontitis has a higher prevalence (32,5 %) 
than in the total population of periodontal patients; moreover, patients with aggressive 
periodontitis were younger than patients with chronic and refractory periodontitis. The 
fact that serotype b seems to be more common in patients with aggressive periodontitis 
could confirm the data that suggest a stronger association with aggressive periodontitis 
for this strain. Nevertheless most of the patients with aggressive periodontitis presented 
serotype a A. a.. This findings may strengthen  the hypothesis suggested by Kaplan of a 
different aetiological pattern for aggressive periodontitis in Caucasian individuals. 
As for the other differences in clinical data, lower PD and higher REC values in refractory 
periodontitis patients reflect the effects of past periodontal therapies, while the lower 
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tendency to bleeding (lower BOP) in patients with chronic periodontitis may depend on 
the effects of smoking, which is more frequent in these group. 
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CONCLUSIONS 
In general we can see the great variation among the different studies, this may be due to 
differences in bacterial detection techniques, ethnicity, geographic location and the 
periodontal condition of the population samples.  
This kind of studies, were the clonal types of bacteria are studied, may help to explain 
why the presence of certain bacterial species is associated with periodontal disease in 
one population group but not in others. 
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FUTURE RESEARCH PROPOSALS 
These data, all proceeding from a Spanish patients, only give us partial information, 
although the sample was well dimensioned and representative of the whole population. 
To allow us a more complete analysis our research team is conducting a new study, in 
collaboration with the University of Rabat, with patients proceeding from Morocco, in 
order to confront data from Spanish and Moroccan patients. 
To complete these analysis another research has been proposed and designed, including 
subjects of Moroccan descents living in Spain, in order to evaluate the presence of 
variations in the distribution of A. a. due to environmental factors. 
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FIGURES AND TABLES 
 
Primer Sequence (5’-3’) Serotype PCR product size 
P11 TCTCCACCATTTTTGAGTGG 
b 
333 pb 
P12 GAAACCACTTCTATTTCTCC 
c 
268 pb 
P13 CCTTTATCAATCCAGACAGC 
f 
232 pb 
P14 AAAACTTCTCATCGGGAATG 
 
 
P15 TGGGTCATGGGAGGTACTCC 
a 293 pb 
P16 GCTAGGAACAAAGCAGCATC 
P17 TGGAACGGGTATGGGAACGG 
d 411 pb 
P18 GGATGCTCATCTAGCCATGC 
P19 ATTCCAGCCTTTTGGTTCTC 
e 311 pb 
P20 TGGTCTGCGTTGTAGGTTGG 
Table 1 Primers selected for the PCR serotyping of A. a. 
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Primer Sequence (5’-3’) Gen PCR product size 
Cdt A
1 
ATGAAGAAGTTTTTACCTGGTC 
CdtA 669 
Cdt A
2 
TAATTAAGGGGTCAAGCTTCT 
Cdt B
1
 TGCAATCCCATTTCGAATTA 
CdtB 851 
Cdt B
2 
TTAGCGATCACGAACAAAAC 
Cdt C
1
 CTTTAGGTACATGTATTGAA 
CdtC 560 
Cdt C
2
 GATGCTTAGTGGGGCGAGGG 
Table 2 Primers used for the detection of the presence of the cdt operon 
 
 
SEROTYPE Monoinfection 72,5 % (29)   Coinfection 27,5% (11) 
Serotype a 37.5 % (15) a + b 54%(6) 
Serotype b 20 %  (8) a + c 28% (3) 
Serotype c 15 %  (6) a + d 19% (2) 
Serotype d 0%    (0) Others 0% (0) 
Serotype e  0%    (0)   
Serotype f 0%    (0)   
Table 3 Distribution of serotype strains for A. a. 
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Table 4 Distribution of ltx gene 
 
 
Table 5 Distribution of cdt gene 
      
 
Ltx gene % (N) 
Ltx C deletion  
(504- bp PCR product) 
0% (0) 
Absence of Ltx deletion 
(1034- bp PCR product) 
100% (40) 
CDT operon % (N) 
Cdt gene presence 
(2016-bp PCR product) 
85% (34) 
Cdt gene absence 
(less than 2016-bp PCR product) 
15% (6) 
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Table 6 Forms of periodontitis 
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Table 7 Presence of cdt gene 
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Table 8 Serotypes 
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Figure 1 and 2 Aggregatibacter actinomycetemcomitans on DENTAID-1 plates 
 
Figures 3 and 4 Examples of different results for PCR performed with serotypes’ 
primers. Electrophoresis on 2.0 % agarose gel with  λ-Hind-III and 1kb dimensional 
markers, respectively. 
 
        
 
 
Serotype a Serotype b Serotype c 
36 
 
 
Figure 5 Examples of results for PCR performed with ltx primers. Electrophoresis on 1.0 
% agarose gel with 1kb dimensional marker. 
 
 
 
Figure 6 Examples of results for PCR performed with cdt primers. Electrophoresis on 
1.0 % agarose gel with 1kb dimensional marker. 
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